Tag: Flagship Biosciences

Flagship Biosciences ActionAssays Deliver Actionable Data to Drive Immuno-Oncology Decisions

| January 16, 2018 | 0 Comments

Flagship Biosciences has introduced a new menu of services to help drug developers more confidently define their path to success. ActionAssays is a comprehensive catalog of brightfield immunohistochemistry (IHC) assays that provide actionable data to define and advance biomarker programs. Flagship Biosciences has introduced a new menu of services to help drug developers more confidently […]

Continue Reading

Flagship Biosciences reaches milestone with “fit-for-purpose” digital pathology services

| April 5, 2015 | 0 Comments

Westminster, CO – April 5, 2015 – Since 2009, Flagship Biosciences has grown to become recognized as the clear industry leader in the delivery of precision pathology reports quantifying a given endpoint in digital pathology. These reports are used in discovery and CLIA clinical trials for measuring a critical biological endpoint for drug or device […]

Continue Reading

Sarepta Therapeutics (SRPT), Flagship Biosciences Enter Digital Pathology Agreement to Automate Dystrophin Measurements

| August 21, 2014 | 0 Comments

CAMBRIDGE, Mass., Aug 20, 2014 — Sarepta Therapeutics, Inc, a developer of innovative RNA-based therapeutics, and Flagship Biosciences LLC, a leading digital pathology firm, today announced a multi-year, multi-product partnership for the development of automated quantitative endpoint measurements in muscular dystrophy to support the advancement Sarepta’s Duchenne muscular dystrophy (DMD) drug pipeline, including its lead […]

Continue Reading

Flagship Biosciences announces agreement in tissue based companion diagnostics development

Flagship Biosciences’ custom image analysis development leverages Leica Biosystems’ strong installed base in digital pathology Boulder, CO – April 30, 2014 – Flagship Biosciences announces it has reached agreement with Leica Biosystems to allow its custom algorithms to be utilized in companion diagnostics development on the Aperio ePathology platform. The agreement allows Flagship’s quantitative analysis […]

Continue Reading

Chicago Bears Refuse To Go Digital

| September 20, 2011 | 0 Comments

The Chicago Bears refuse to go digital, sound familiar?

Continue Reading

Killer App Discovered for Digital Pathology

| August 10, 2011 | 0 Comments

Newark Airport has been revealed as the killer application in digital pathology adoption

Continue Reading

Pathology publisher goes digital

| June 24, 2011 | 0 Comments

Publisher goes digital with whole slide imaging for pathology review

Continue Reading

Tissue-based proteomics meets digital pathology

| December 29, 2010 | 0 Comments

Expression Pathology and Flagship Biosciences recently announced a services alliance in tissue-based proteomics, combining digital pathology with mass-spec FFPE tissue proteomics. While this collaboration is oriented towards research and companion diagnostics development, mass spec is making rapid inroads in all areas of clinical applications, including tissue. The ability to run protein expression in FFPE instead of […]

Continue Reading

No black eyes with digital slides – walk us through the case

| November 9, 2010 | 0 Comments

Work out while working your case! Only with digital slides

Continue Reading